Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 42 entries
View as:

Assess the Effect of Food on Avanafil Pharmacokinetic (PK), to Compare 2 Oral Formulations of Avanafil,and Investigate Dose Proportionality in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01095601 Org: User:
Start: 04/30/10 End: 05/31/10 Due: 05/31/11

Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02229214 Org: User:
Start: 08/31/14 End: 11/30/14 Due: 11/30/15

Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00853606 Org: User:
Start: 03/31/09 End: 04/30/10 Due: 04/30/11

A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05215418 Org: User:
Start: 01/25/22 End: 04/17/23 Due: 04/17/24

A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00768404 Org: User:
Start: 10/31/08 End: 07/31/09 Due: 07/31/10

Hemodynamic Study of Avanafil and Two α-Adrenergic Blockers,Doxazosin and Tamsulosin

Phase: N/A Priority: Normal
NCT ID: NCT01100021 Org: User:
Start: 02/28/10 End: 04/30/10 Due: 04/30/11

Drug Interaction Study of Avanafil and Enalapril or Amlodipine

Phase: N/A Priority: Normal
NCT ID: NCT01117038 Org: User:
Start: 04/30/10 End: 05/31/10 Due: 05/31/11

Safety Study Looking at the Effects of Stendra on Vision

Phase: N/A Priority: Normal
NCT ID: NCT02033200 Org: User:
Start: 01/31/14 End: 01/31/14 Due: 01/31/15

A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00842400 Org: User:
Start: 02/28/09 End: 04/30/09 Due: 04/30/10

A Phase I Crossover Study of the Hemodynamic Interactions of Avanafil & Alcohol in Healthy Male Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT01054859 Org: User:
Start: 01/31/10 End: 01/31/10 Due: 01/31/11

Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and Placebo

Phase: N/A Priority: Normal
NCT ID: NCT01616485 Org: User:
Start: 03/31/04 End: 05/31/04 Due: 05/31/05

A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00768209 Org: User:
Start: 10/31/08 End: 07/31/09 Due: 07/31/10

Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic Adults

Phase: N/A Priority: Normal
NCT ID: NCT00737633 Org: User:
Start: 08/31/08 End: 06/30/09 Due: 06/30/10

Study the Effect of Avanafil on the Pharmacodynamics and Pharmacokinetics of Warfarin in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01095588 Org: User:
Start: 04/30/10 End: 05/31/10 Due: 05/31/11

Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT01698684 Org: User:
Start: 09/30/12 End: 04/30/13 Due: 04/30/14

A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00806260 Org: User:
Start: 12/31/08 End: 05/31/09 Due: 05/31/10

A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00563368 Org: User:
Start: 12/31/07 End: 09/30/08 Due: 09/30/09

A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese Adults

Phase: N/A Priority: Normal
NCT ID: NCT00745251 Org: User:
Start: 08/31/08 End: 12/31/09 Due: 12/31/10

To Compare the Pharmacokinetics of Avanafil in Subjects With Mild and Moderate Renal Impairment to Subjects With Normal Renal Function.

Phase: N/A Priority: Normal
NCT ID: NCT01054261 Org: User:
Start: 01/31/10 End: 02/28/10 Due: 02/28/11

A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT03922945 Org: User:
Start: 05/02/19 End: 04/16/21 Due: 04/16/22

A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)

Phase: N/A Priority: Normal
NCT ID: NCT00796367 Org: User:
Start: 12/31/08 End: 07/31/10 Due: 07/31/11

Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00553787 Org: User:
Start: 11/30/07 End: 06/30/09 Due: 06/30/10

Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults

Phase: N/A Priority: Normal
NCT ID: NCT00518466 Org: User:
Start: 07/31/07 End: 12/31/07 Due: 12/31/08

Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED

Phase: N/A Priority: Normal
NCT ID: NCT00790751 Org: User:
Start: 11/30/08 End: 08/31/09 Due: 08/31/10

A Pharmacokinetic Study of Avanfil in Healthy Young Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00914511 Org: User:
Start: 05/31/09 End: 06/30/09 Due: 06/30/10